Echinacea Symposium Presents New Research On Chernobyl Victims

The results from a long-term clinical study in the Ukraine on the use of Echinacea to treat victims of the Chernobyl disaster is among the new studies to be presented at the 1999 International Echinacea Symposium June 3-5 in Kansas City, MO.

Dr. Victoriya F. Pochernyayeva, a leading researcher from Ukraine and the former Soviet Union, will review the results of her long-term studies including:

  • An analysis of how effectively Echinacea purpurea, consumed as a food additive in fruit juices and other non-alcoholic and alcoholic drinks, protects people who are exposed to radiation. Based on her findings, Dr. Pochernyayeva recommends ways Echinacea purpurea food additives can be used most effectively to safeguard a population that is facing high levels of radiation exposure;
  • A study of how Echinacea purpurea can protect the male reproductive system from the effects of radiation;
  • A study of how effectively Echinacea purpurea can protect organs and tissues from radiation damage.

The world's leading Echinacea researcher, Dr. Rudolf Bauer, is the keynote speaker. Dr. Bauer, professor at the Institute of Pharmaceutical Biology, University of Dusseldorf, has published more than 100 research papers and has edited a book on Echinacea. He's currently researching the quality aspects of Echinacea preparations, constituents and pharmacological activity of Echinacea species.

The event is hosted by the American Herbal Products Association. Sponsors include Nature's Way, Botanicals International, Bioforce USA, Finzelberg North America, Rexall Sundown, Indena USA, and Plantation Medicinals.

Who: Some 150 researchers, scientists and other professionals from the herbal industry.

What: 1999 International Echinacea Symposium

Where: Ritz-Carlton, Kansas City, MO.

When: June 3-5, 1999

Why: To present the latest clinical research, and learn about the

Contact: Brian Ruberry
American Herbal Products Association

Page: 1 2 3

Related biology news :

1. NIH funds botanical center in Iowa to study health effects of Echinacea and St. Johns wort
2. Worlds Leading Echinacea Researchers To Examine Latest Scientific Findings On "Natures Gentle Antibiotic"
3. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
4. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
5. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
6. Health of worlds sea lions the focus of Wakefield Symposium
7. Chemical signals health of brain cells Symposium
8. Final Alert: 16th EORTC NCI AACR Symposium
9. 16th EORTC NCI AACR Symposium
10. Symposium to tackle questions of genetic engineering and biodiversity
11. Fostering Diversity in the Sciences Symposium

Post Your Comments:

(Date:6/23/2017)... N.Y. , June 23, 2017  IBM (NYSE: ... dairy research, today announced a new collaboration using next-generation ... chances that the global milk supply is impacted by ... Cornell University has become the newest academic institution to ... a food safety initiative that includes IBM Research, Mars, ...
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/24/2017)... 2017 Janice Kephart , former ... Strategy Partners, LLP (IdSP) , today issues the ... Trump,s March 6, 2017 Executive Order: Protecting ... can be instilled with greater confidence, enabling the ... refugee applications are suspended by until at least ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity of ... performing systematic gain-of-function studies. , This complement to loss-of-function studies, such as ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
Breaking Biology Technology:
Cached News: